Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients

BACKGROUND: The association between intravenous (IV) iron administration and outcomes in hemodialysis (HD) patients is still debated. Therefore, this study was aimed to assess the relationship between the IV administration of ferric chloride hexahydrate (Atofen®) and cardiovascular (CV) outcome and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Ko-Lin, Hung, Szu-Chun, Lin, Yao-Ping, Tang, Ching-Fang, Lee, Tzong-Shyuan, Lin, Chih-Pei, Tarng, Der-Cherng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515606/
https://www.ncbi.nlm.nih.gov/pubmed/23227165
http://dx.doi.org/10.1371/journal.pone.0050295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515606/
https://www.ncbi.nlm.nih.gov/pubmed/23227165
http://dx.doi.org/10.1371/journal.pone.0050295

Ejemplares similares